These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications. Lauria F; Bocchia M; Marotta G; Raspadori D; Zinzani PL; Rondelli D Haematologica; 1999 Jan; 84(1):22-5. PubMed ID: 10091389 [TBL] [Abstract][Full Text] [Related]
5. The development of congestive cardiac failure in a patient with hairy cell leukemia treated with 2-chlorodeoxyadenosine. Koczwara B; Spangenthal E; Bernstein SH Leuk Lymphoma; 1997 Jul; 26(3-4):413-5. PubMed ID: 9322907 [TBL] [Abstract][Full Text] [Related]
6. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies]. Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060 [TBL] [Abstract][Full Text] [Related]
7. Severe skin rash in two consecutive patients treated with 2-chlorodeoxyadenosine for hairy cell leukaemia at a single institution. Grey MR; Flanagan NG; Kelsey PR Clin Lab Haematol; 2000 Apr; 22(2):111-3. PubMed ID: 10792402 [TBL] [Abstract][Full Text] [Related]
8. Novel antibodies reacting with two neighboring gangliosides are induced in rabbits immunized with bovine brain gangliosides. Moyano AL; Comín R; Vilcaes AA; Funes SC; Roth GA; Irazoqui FJ; Nores GA Glycobiology; 2012 Dec; 22(12):1768-74. PubMed ID: 22843673 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. Gregson NA; Koblar S; Hughes RA Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986 [TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome. Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979 [TBL] [Abstract][Full Text] [Related]
11. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy. Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296 [TBL] [Abstract][Full Text] [Related]
12. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders. Kusunoki S; Kaida K J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559 [TBL] [Abstract][Full Text] [Related]
13. [Subcutaneous therapy of hairy cell leukemia with 2-chlorodeoxyadenosine]. Nielsen OJ; Hippe E; Priø TK; Juliusson G Ugeskr Laeger; 1994 Apr; 156(16):2407-9. PubMed ID: 7912015 [TBL] [Abstract][Full Text] [Related]
14. Anti-asialo-GM1 and GD1a variant of Miller Fisher variant of Guillain-Barré Syndrome. Morgan ML; Law N; Espino Barros Palau A; Saeed U; Yalmanchili S; Lee AG J Neuroophthalmol; 2014 Dec; 34(4):377-9. PubMed ID: 25062498 [TBL] [Abstract][Full Text] [Related]
15. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies]. Tagawa Y; Matsumoto Y; Yuki N No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308 [TBL] [Abstract][Full Text] [Related]
16. [A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome]. Watanabe H; Shindo K; Nakamura Y; Nagamatsu M; Shiozawa Z; Kusunoki S Rinsho Shinkeigaku; 2001 Sep; 41(9):625-7. PubMed ID: 11968750 [TBL] [Abstract][Full Text] [Related]